MILENA LOBAINA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GALVESTON, TX NPI 1265057731
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TX ABBVIE INC. All categories
General Payments — all program years on this page
$589.81
- Category: General Payments
- Program years: PY2021–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $196.99 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.99 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $86.35 | 4 |
| SK Life Science, Inc. | $33.18 | 1 |
| Sandoz Inc. | $29.70 | 1 |
| ARGENX US, INC. | $29.36 | 1 |
| Acorda Therapeutics, Inc | $18.40 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089374873 | Sandoz Inc. | $29.70 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104893849 | ABBVIE INC. | $16.94 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104893851 | ABBVIE INC. | $16.15 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104893853 | ABBVIE INC. | $28.36 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104893855 | ABBVIE INC. | $24.90 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142127255 | ARGENX US, INC. | $29.36 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142349256 | Acorda Therapeutics, Inc | $18.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154124797 | SK Life Science, Inc. | $33.18 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.